首頁 > 市場調查報告書 > 製藥

再生醫學

市場調查報告書

商品編碼

1673847

富血小板血漿市場：依類型、來源、應用和地區

Platelet Rich Plasma Market, By Type, By Origin, By Application, By Geography

出版日期: 2025年02月13日 | 出版商:

Coherent Market Insights | 英文 184 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025年全球富血小板血漿市場規模估計為 6.205億美元，預計到2032年將達到 14.337億美元，2025-2032年的年複合成長率（CAGR）為 12.7%。

報告範圍		報告詳細資訊
基準年	2024	2025年市場規模	6.205億美元
歷史資料	2020-2024	預測期	2025-2032
預測期：2025-2032年年複合成長率	12.70％	2032年金額預測	14.337億美元

圖表.2025年富血小板血漿市場佔有率（%）（依地區分類）

富血小板血漿（PRP）是從少量全血中提取的血小板濃縮物。富含血小板的血漿含有多種已知可促進組織再生的生長因子。富含血小板血漿療法是一種即將問世的治療方法多種肌肉骨骼疾病的方法，包括肌腱炎、關節損傷和關節炎。血小板分泌的生長因子會透過吸引幹細胞、刺激細胞增生和分化來誘導組織癒合。隨著運動傷害和退化性疾病的日益流行，富血小板血漿已成為外科手術和組織修復藥物的有希望的替代品。

市場動態

最近的趨勢表明，富含血小板血漿由於其再生特性被各個治療領域迅速採用。運動醫學的發展和肌肉骨骼疾病病例的增加是該市場的主要驅動力。然而，富含血小板血漿程序和設備的高成本可能會阻礙更廣泛的採用。廉價的富血小板血漿製備套件的開發提供了巨大的機會。市場領導投資研發以擴大核准的臨床適應症。例如，監管部門核准使用富含血小板的血漿進行臉部回春開闢了新的途徑。

研究的主要特點

本報告對全球富血小板血漿市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模（百萬美元）和年複合成長率（CAGR%），假設2024年為基準年。
強調了各個領域的潛在收益成長機會，並解釋了該市場的有吸引力的投資提案矩陣。
提供關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
全球富血小板血漿市場的主要企業根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行分析。
主要企業包括 Arthrex, Inc.、Ester Medical、Zimmer Biomet、Terumo Corporation、Glofinn Oy、Medira Ltd.、Regen Lab SA、CollPlant、Generex BIoTechnology Corporation、Estar Technologies Ltd.、Cesca Therapeutics, Inc.、Arteriocyte Medical、Harvestal Corporation.
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球富血小板血漿市場迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員可以透過全球富含血小板血漿市場分析中使用的各種策略矩陣來促進他們的決策。

公司簡介
- Arthrex, Inc.
- Ester Medical
- Zimmer Biomet
- Terumo Corporation
- Glofinn Oy
- Medira Ltd.
- Regen Lab SA
- CollPlant
- Generex BIoTechnology Corporation
- Estar Technologies Ltd.
- Cesca Therapeutics, Inc.
- Arteriocyte Medical Systems
- Harvest Technologies Corp.
- EmCyte Corporation
- T-BIoTechnology Ltd.
- Isto Biologics

第10章分析師觀點

興衰
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI936

Global Platelet Rich Plasma Market is estimated to be valued at USD 620.5 Mn in 2025 and is expected to reach USD 1,433.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 12.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 620.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	12.70%	2032 Value Projection:	USD 1,433.7 Mn

Figure. Platelet Rich Plasma Market Share (%), By Region 2025

Platelet Rich Plasma (PRP) is an enriched concentration of platelets extracted from a small volume of whole blood. It contains several growth factors that are known to accelerate tissue regeneration. PRP therapy is an upcoming treatment for various musculoskeletal conditions such as tendonitis, joint injuries, and arthritis. The secretion of growth factors from platelets induces tissue healing by attracting stem cells and stimulating cell proliferation and differentiation. With the increasing prevalence of sports injuries and degenerative conditions, PRP is emerging as a promising alternative to surgical interventions and medications for tissue repair.

Market Dynamics:

Recent trends indicate the rapid adoption of PRP in various therapeutic areas due to its regenerative properties. Growth in sports medicine and rising cases of musculoskeletal disorders are major drivers for this market. However, high costs associated with PRP procedures and equipment may restrain wider adoption. The development of inexpensive PRP preparation kits presents significant opportunities. Market leaders are investing in R&D to expand approved clinical indications. For example, regulatory approvals for use of PRP in facial rejuvenation opens new avenues.

Key Features of the Study:

This report provides an in-depth analysis of the global platelet rich plasma market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global platelet rich plasma market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this Arthrex, Inc., Ester Medical, Zimmer Biomet, Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, Estar Technologies Ltd., Cesca Therapeutics, Inc., Arteriocyte Medical Systems, Harvest Technologies Corp., EmCyte Corporation, T-Biotechnology Ltd., and Isto Biologics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global platelet rich plasma market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global platelet rich plasma market.

Detailed Segmentation-

By Type:
- Pure PRP
- Leukocyte rich PRP
- Pure PRF
- Leukocyte rich PRF
By Origin:
- Autologous
- Allogenic
- Homologues
By Application:
- Neurosurgery
- Cosmetic Surgery
- Orthopedic Surgery
- General Surgery
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa

Company Profiles:

Arthrex, Inc.
Ester Medical
Zimmer Biomet
Terumo Corporation
Glofinn Oy
Medira Ltd.
Regen Lab S.A.
CollPlant
Generex Biotechnology Corporation
Estar Technologies Ltd.
Cesca Therapeutics, Inc.
Arteriocyte Medical Systems
Harvest Technologies Corp.
EmCyte Corporation
T-Biotechnology Ltd.
Isto Biologics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Origin
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Platelet Rich Plasma Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Platelet Rich Plasma Market, By Type, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Pure PRP
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Leukocyte rich PRP
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Pure PRF
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Leukocyte rich PRF
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Platelet Rich Plasma Market, By Origin, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Autologous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Allogenic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Homologues
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Platelet Rich Plasma Market, By Application, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Neurosurgery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cosmetic Surgery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Orthopedic Surgery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
General Surgery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Platelet Rich Plasma Market, By Region, 2020 - 2032, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- GCC
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
- North Africa
- Central Africa
- South Africa

9. Competitive Landscape

Company Profiles
- Arthrex, Inc.*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ester Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zimmer Biomet
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Glofinn Oy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medira Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Regen Lab S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CollPlant
- Generex Biotechnology Corporation
- Estar Technologies Ltd.
- Cesca Therapeutics, Inc.
- Arteriocyte Medical Systems
- Harvest Technologies Corp.
- EmCyte Corporation
- T-Biotechnology Ltd.
- Isto Biologics